Usefulness of 5 Minutes 123I-mIBG Scan in Parkinson’s Disease and Heart Failure

Author:

Frantellizzi Viviana1ORCID,Ricci Maria2ORCID,Farcomeni Alessio3ORCID,Pontico Mariano4ORCID,Pani Arianna5ORCID,Vincentis Giuseppe De2ORCID

Affiliation:

1. Department of Molecular Medicine, Sapienza, “Sapienza” University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy

2. Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza, “Sapienza” University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy

3. Department of Economics and Finance, University of Rome “Tor Vergata”, Via Columbia, 2, 00133, Rome, Italy

4. Ph.D. Program in Morphogenesis & Tissue Engineering, Sapienza University of Rome, Rome, Italy

5. Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan “Statale”, Italy

Abstract

Background: The use of 123I-mIBG has been approved for decades for Parkinson’s disease (PD) diagnosis and as a predictor of mortality and potentially fatal events in patients with Heart Failure (HF). The standardized technique includes an early acquisition (15 minutes from injection), and a late acquisition (240 minutes). Early images mainly represent interstitial uptake, whereas delayed images represent actual neuronal uptake, however, it is reasonable to affirm that different pathological situations, such as PD and HF, imply a different meaning for early and late imaging. Objective: This prospective study aims to investigate the clinical usefulness of an immediate planar 123I-mIBG image acquisition (5 minutes) both in patients with PD and in patients with HF. Methods: 115 patients referred to 123I-mIBG cardiac imaging in Nuclear Medicine Center have been enrolled (60 patients with PD, absence of diabetes and/or cardiologic pathology, Hoehn e Yahr classification ≤ 1.5; 55 patients with cardiomyopathy, diagnosis of HF, NYHA class I–III). 123I-mIBG planar anterior thoracic acquisitions were performed after 5 (immediate), 15 (early) and 240 (late) minutes from injection and H/M ratios were calculated. Results: In PD group H/M mean values resulted in 1.58±0.22 for immediate (5 min), 1.61±0.26 for early (15 min) and 1.59±0.37 for late (240 min) acquisitions. In the HF group, H/M mean values resulted in 1.63±0.24 for immediate (5 min), 1.65±0.22 for early (15 min) and 1.57±0.17 for late (240 min) acquisitions, respectively. H/M values obtained at 5 min and 15 min are provided similar results, with no statistical difference (p = ns) regardless of the pathology examined (PD or HF groups). The statistical analyses validated the diagnostic role of immediate acquisition (5 min) and early acquisition (15 min) in PD group as compared to the standardized late acquisition (240 min). On the contrary, in HF group, immediate and early acquisition, as compared to late acquisition (240 min), is not validated as a major cardiac events predictor. Conclusion: Our results indicate the potential role of immediate (5 min) or early (15 min) acquisition in replacement of standardized 240 minutes acquisition in PD patients, but this result is not confirmed in HF patients, in which the acquisition at 240 min is confirmed as the most affordable timing for image interpretation, emphasizing the different pathophysiology that underlies these two pathologies.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Radiology, Nuclear Medicine and imaging

Reference26 articles.

1. Nakajima,K.; Verschure, D.O.; Okuda,K.; Verberne, H.J. Standardi-zation of 123I-meta-iodobenzylguanidine myocardial sympathetic activ-ity imaging: phantom calibration and clinical applications. Clin. Transl. Imaging. 2017,5(3),255-263. http://dx.doi.org/10.1007/s40336-017-0230-2 PMID: 28596948

2. Verberne.; H.J. Assessment of cardiac sympathetic innervation with (123) I-mIBG SPECT comes to life: need for standardization Eur. Heart J. Cardiovasc. Imaging. 2016,17(4),391-392. http://dx.doi.org/10.1093/ehjci/jev348 PMID: 26819325

3. Boogers, M.J.; Borleffs, C.J.; Henneman, M.M.; van Bommel, R.J.; van Ramshorst,J.; Boersma,E.; Dibbets-Schneider,P.; Stokkel, M.P.; van der Wall, E.E.; Schalij, M.J.; Bax, J.J. Cardiac sympathetic dener-vation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients, J. Am. Coll. Cardiol. 2010,55(24),2769-2777. http://dx.doi.org/10.1016/j.jacc.2009.12.066 PMID: 20538172

4. Nuvoli,S.; Palumbo,B.; Malaspina,S.; Madeddu,G.; Spanu, A. 123I-ioflupane SPET and 123I-MIBG in the diagnosis of Parkinson’s disease and parkinsonian disorders and in the differential diagnosis between Alzheimer’s and Lewy’s bodies dementias. Hell, J. Nucl. Med. 2018,21(1),60-68. PMID: 29550847

5. Jacobson, A.F.; Senior,R.; Cerqueira, M.D.; Wong, N.D.; Thomas, G.S.; Lopez, V.A.; Agostini,D.; Weiland,F.; Chandna,H.; Narula, J. ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Re-sults of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study, J. Am. Coll. Cardiol. 2010,55(20),2212-2221. http://dx.doi.org/10.1016/j.jacc.2010.01.014 PMID: 20188504

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3